| Category | Cardio Product Range |
|---|---|
| Brand Name | Scabutol-50 |
| Composition | Sacubitril 24mg + Valsartan 26mg Tablet |
| Packing | 10X14 Alu Alu |
Sacubitril / Valsartan Tablets
Sacubitril and Valsartan tablets are used to treat heart failure. This innovative medication brings together two distinct mechanisms of action to effectively manage heart failure with reduced ejection fraction (HFrEF), offering patients a new ray of hope for improved cardiac health.
Sacubitril:
Sacubitril is a neprilysin inhibitor that works by blocking an enzyme responsible for breaking down beneficial peptides in the heart. By inhibiting neprilysin, Sacubitril increases the levels of these peptides, which have vasodilatory, diuretic, and natriuretic effects. This leads to the relaxation and dilation of blood vessels, reducing the workload on the heart and improving overall cardiac function. Sacubitril contributes to symptomatic relief and helps enhance the patient’s quality of life
Valsartan:
Valsartan is an angiotensin receptor blocker (ARB) that acts on the renin-angiotensin-aldosterone system (RAAS). By blocking the action of angiotensin II on blood vessels and adrenal glands, Valsartan promotes vasodilation and reduces blood pressure. Additionally, it helps prevent the adverse remodelling of the heart muscles that often occurs in heart failure. Valsartan’s ability to modulate the RAAS system plays a crucial role in managing the progression of heart failure.
Sacubitril/Valsartan Tablets are medications that can only be prescribed by a doctor for the management of chronic heart failure with reduced ejection fraction (HFrEF).
This medicine should never be taken in combination with ACE inhibitors
Note: At least 36 hours must elapse between stopping an ACE inhibitor and starting sacubitril/valsartan tablets to prevent angioedema.
Sacubitril/Valsartan is an evidence-based first-line treatment option in the management of:
It is endorsed by key cardiological practice guidelines (AHA/ACC, ESC) as an alternative to ACE inhibitors or ARBs in appropriate cases.
This medicine combines two complementary mechanisms:
Sacuitril (Neprilysin Inhibitor)
Blocks neprilysin enzyme
Increases beneficial natriuretic peptides
Leads to:
Valsartan (ARB – Angiotensin II Blocker)
Blocks angiotensin II receptors
Leads to:
Combined Effect:
Enhanced Cardiac Function: The combination improves heart function by promoting vasodilation and reducing fluid retention.
Reduced Mortality and Hospitalizations: Clinical trials show a significant decrease in cardiovascular mortality and heart failure-related hospitalizations.
Symptomatic Relief: Patients experience relief from symptoms like shortness of breath and fatigue, leading to improved daily comfort.
Slowed Disease Progression: Adverse cardiac remodelling is slowed, preserving heart function and potentially delaying interventions.
Simplified Regimen: Combining two mechanisms of action in one tablet streamlines treatment and enhances adherence.
Improved Quality of Life: Symptom relief and better cardiac health contribute to an enhanced overall quality of life.
Recognised Efficacy: Approved by authorities and endorsed in clinical guidelines, indicating proven efficacy and safety.
Do not use this medicine if:
Serious risks include:
Any patient that is on Sacubitril/Valsartan should go through regular monitoring:
Avoid or use caution with:
Sacubitril/Valsartan is used to treat chronic heart failure with reduced ejection fraction. It helps to improve heart function and reduce symptoms. This lowers the risk of hospitalisation and death.
Yes, it is many times prescribed as a replacement for ACE inhibitors or ARBs in eligible patients. You have to maintain a 36-hour gap when you’re switching from an ACE inhibitor.
You may see some symptom improvement within a few weeks, but full benefits, including reduced hospitalization risk, occur with long-term use.
No, it is mostly indicated for heart failure and is not recommended as a routine treatment for hypertension alone unless and until it is prescribed by a doctor.
You should avoid potassium supplements, any salt substitutes that contain potassium, NSAIDs and alcohol. Also, do not take it with ACE inhibitors.
Take the missed dose as soon as you remember. If it is close to your next dose, skip the missed one. Do not take a double dose.
No, it’s not meant to be used during pregnancy as that may cause serious harm to the unborn baby.